281 related articles for article (PubMed ID: 16522603)
1. Implications of Part D for mentally ill dual eligibles: a challenge for Medicare.
Morden NE; Garrison LP
Health Aff (Millwood); 2006; 25(2):491-500. PubMed ID: 16522603
[TBL] [Abstract][Full Text] [Related]
2. Dual eligibles with mental disorders and Medicare part D: how are they faring?
Donohue JM; Huskamp HA; Zuvekas SH
Health Aff (Millwood); 2009; 28(3):746-59. PubMed ID: 19414883
[TBL] [Abstract][Full Text] [Related]
3. Mental health in the Medicare Part D drug benefit: a new regulatory model?
Donohue J
Health Aff (Millwood); 2006; 25(3):707-19. PubMed ID: 16684735
[TBL] [Abstract][Full Text] [Related]
4. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
[TBL] [Abstract][Full Text] [Related]
5. Medicare Part D: how do vulnerable beneficiaries fare?
Summer L; Nemore P; Finberg J
Issue Brief (Commonw Fund); 2008 Apr; 35():1-11. PubMed ID: 18536146
[TBL] [Abstract][Full Text] [Related]
6. Coverage and prior authorization of psychotropic drugs under Medicare Part D.
Huskamp HA; Stevenson DG; Donohue JM; Newhouse JP; Keating NL
Psychiatr Serv; 2007 Mar; 58(3):308-10. PubMed ID: 17325102
[TBL] [Abstract][Full Text] [Related]
7. Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.
Hall JP; Kurth NK; Moore JM
Am J Manag Care; 2007 Jan; 13(1):14-8. PubMed ID: 17227199
[TBL] [Abstract][Full Text] [Related]
8. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
Thomas CP; Sussman J; ;
Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
[TBL] [Abstract][Full Text] [Related]
9. Suicidality is associated with medication access problems in publicly insured psychiatric patients.
MoĊcicki EK; West JC; Rae DS; Rubio-Stipec M; Wilk JE; Regier DA
J Clin Psychiatry; 2010 Dec; 71(12):1657-63. PubMed ID: 21190639
[TBL] [Abstract][Full Text] [Related]
10. 'Dual eligibles' may have trouble getting psychiatric meds under Part D.
Med Health; 2005 Aug; 59(29):2-4. PubMed ID: 16161618
[No Abstract] [Full Text] [Related]
11. The new Medicare prescription drug benefit: important issues for physician practices.
Falk R; Stranne S
J Med Pract Manage; 2005; 21(3):133-7. PubMed ID: 16471382
[TBL] [Abstract][Full Text] [Related]
12. States' control of prescription drug spending: a heterogeneous approach.
Morden NE; Sullivan SD
Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
[TBL] [Abstract][Full Text] [Related]
13. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
Sengupta S
N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
[TBL] [Abstract][Full Text] [Related]
14. Variation in psychotropic drug use in nursing homes.
Castle NG
J Health Soc Policy; 1998; 10(3):13-36. PubMed ID: 10185054
[TBL] [Abstract][Full Text] [Related]
15. Medicare Part D: practical practice information for healthcare providers.
Moczygemba LR
J Am Acad Nurse Pract; 2006 Oct; 18(10):457-62. PubMed ID: 16999710
[TBL] [Abstract][Full Text] [Related]
16. Plan formularies fail to provide dual eligibles with access to critical meds.
Med Health; 2006 Feb; 60(7):3, 7-8. PubMed ID: 16494129
[No Abstract] [Full Text] [Related]
17. Prescription drug benefits under Part D of the Medicare Modernization Act--the genie's out of the bottle.
Andersen LS
Issue Brief Cent Medicare Educ; 2005; 5(10):1-10. PubMed ID: 15943013
[TBL] [Abstract][Full Text] [Related]
18. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
Dale SB; Verdier JM
Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
[No Abstract] [Full Text] [Related]
19. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
Docherty JP; Browne RA; Farmer M
Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
[TBL] [Abstract][Full Text] [Related]
20. High-cost users among dual eligibles in three care settings.
Yip J; Nishita CM; Crimmins EM; Wilber KH
J Health Care Poor Underserved; 2007 Nov; 18(4):950-65. PubMed ID: 17982217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
